Akira Olivia

Akira Olivia is a journalist who focuses on health and social issues. She has written extensively on the topic of health disparities, particularly in relation to race and gender. Her work is characterized by a strong commitment to highlighting systemic issues and advocating for change.

94%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

85%

Examples:

  • In the article 'Black women are dying from breast cancer at a higher rate. Here’s why', the author seems to favor systemic changes to address the higher mortality rates among Black women.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Merck's Efforts in Addressing Triple-Negative Breast Cancer and Racial Disparities

Broke On: Tuesday, 15 February 2022 Triple-negative breast cancer (TNBC) is a particularly aggressive form of the disease that disproportionately affects Black women. Black women are nearly twice as likely to be diagnosed with TNBC compared to their white counterparts. Racial disparities persist in breast cancer mortality rates, with Black women having a 40% higher breast cancer death rate compared to white women. Merck is developing innovative therapies and promoting health equity to address TNBC and the racial disparities in breast cancer mortality rates.